NEUROCRINE BIOSCIENCES

neurocrine-biosciences-logo

Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company develops drugs for endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine related diseases and disorders. Its products in clinical development comprise Elagolix, a Phase II product for Endometriosis; CRF1 Antagonist, a phase II product for mood... disorders; CRF2 Peptide Agonist, a phase II drug for Cardiovascular related diseases; CRF1 Antagonist, a Phase I product for treating Mood Disorders and Irritable Bowel Syndrome; and Elagolix, a Phase I product for treating Benign Prostatic Hyperplasia and Uterine Fibroids. The company's research programs include Vesicular Monoamine Transporter 2 Inhibitor for movement disorders and schizophrenia; Glucose Dependent Insulin Secretagogues for type II diabetes; Antiepileptic drugs for epilepsy and bipolar disorder; and GnRH Antagonists for hormone dependent diseases and oncology. It has strategic alliances with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; and Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize indiplon in Japan. Neurocrine Biosciences, Inc. was founded in 1992 and is based in San Diego, California.

#SimilarOrganizations #People #Financial #Event #Website #More

NEUROCRINE BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1992-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.neurocrine.com

Total Employee:
251+

Status:
Active

Contact:
(858) 617-7600

Email Addresses:
[email protected]

Total Funding:
10 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics


Similar Organizations

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.


Current Advisors List

richard-pops_image

Richard Pops Member of the Board of Directors @ Neurocrine Biosciences
Board_member

not_available_image

George Morrow Board Member @ Neurocrine Biosciences
Board_member
2015-10-01

shalini-sharp_image

Shalini Sharp Board Member @ Neurocrine Biosciences
Board_member

william-rastetter_image

William Rastetter Chairman of the Board of Directors @ Neurocrine Biosciences
Board_member

leslie-v-norwalk_image

Leslie V. Norwalk Board Member @ Neurocrine Biosciences
Board_member
2019-09-01

Current Employees Featured

kevin-c-gorman_image

Kevin C. Gorman
Kevin C. Gorman CEO @ Neurocrine Biosciences
CEO
1993-01-01

christopher-obrien_image

Christopher O&s;Brien
Christopher O'Brien Chief Medical Officer @ Neurocrine Biosciences
Chief Medical Officer

david-boyer_image

David Boyer
David Boyer Chief Corporate Affairs Officer @ Neurocrine Biosciences
Chief Corporate Affairs Officer
2019-09-01

darin-lippoldt_image

Darin Lippoldt
Darin Lippoldt Chief Legal Officer @ Neurocrine Biosciences
Chief Legal Officer
2014-10-01

malcolm-lloyd-smith_image

Malcolm Lloyd-Smith
Malcolm Lloyd-Smith Chief Regulatory Officer @ Neurocrine Biosciences
Chief Regulatory Officer
2014-09-01

eric-benevich_image

Eric Benevich
Eric Benevich Chief Commercial Officer @ Neurocrine Biosciences
Chief Commercial Officer
2015-05-01

eiry-roberts_image

Eiry Roberts
Eiry Roberts Chief Medical Officer @ Neurocrine Biosciences
Chief Medical Officer
2018-01-01

not_available_image

Dimitri Grigoriadis
Dimitri Grigoriadis Chief Research Officer @ Neurocrine Biosciences
Chief Research Officer
2013-01-01

julie-cooke_image

Julie Cooke
Julie Cooke Chief Human Resources Officer @ Neurocrine Biosciences
Chief Human Resources Officer
2017-09-01

not_available_image

Jude Onyia
Jude Onyia Chief Scientific Officer @ Neurocrine Biosciences
Chief Scientific Officer
2021-11-01

Founder


errol-de-souza_image

Errol De Souza

larry-bock_image

Larry Bock

wylie-vale_image

Wylie Vale

Stock Details


Company's stock symbol is NASDAQ:NBIX

Acquisitions List

Date Company Article Price
2022-08-30 Diurnal Group Diurnal Group acquired by Neurocrine Biosciences 48.3 M GBP
1998-03-03 Northwest Neurologic Northwest Neurologic acquired by Neurocrine Biosciences N/A

Investors List

venrock_image

Venrock

Venrock investment in Post-IPO Equity - Neurocrine Biosciences

Investments List

Date Company Article Money raised
2019-12-02 Xenon Pharmaceuticals Neurocrine Biosciences investment in Post-IPO Equity - Xenon Pharmaceuticals 30 M USD

Official Site Inspections

http://www.neurocrine.com Semrush global rank: 1.61 M Semrush visits lastest month: 15.68 K

  • Host name: 20.119.8.58
  • IP address: 20.119.8.58
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Neurocrine Biosciences" on Search Engine